| (V1562) |
Cardiomyocyte-specific Tissue Factor knock out attenuates myocardial inflammation during CVB3-induced myocarditis |
|
R. Malz, S. Antoniak, H.-P. Schultheiss, U. Rauch-Kröhnert (Berlin; Chapel Hill, US) |
| (V1563) |
Deletion of the coronary artery disease risk gene ADAMTS-7 prevents structural remodelling of injured vessels without effects on metabolic parameters or lipid deposition |
|
T. Keßler, Z. Aherrahrou, K. Schmidt, C. de Wit, H. Schunkert, J. Erdmann (Lübeck) |
| (V1564) |
Cardiac alpha-myosin (MYH6) is the predominant sarcomeric disease gene for familial atrial septal defects |
|
M. Posch, S. Waldmüller, A. Perrot, T. Scheffold, K. Schmitt, M. Andrade-Navarro, P. Bouvagnet, F. Berger, R. Hetzer, C. Özcelik (Berlin, Dortmund, Freiburg im Breisgau, Northeim; Lyon, FR) |
| (V1565) |
MED10 regulates the formation of the atrioventricular canal by controlling Tbx2b expression in the embryonic zebrafish heart |
|
I. Berger, S. Just, W. Rottbauer (Ulm) |
| (V1566) |
BRAP2 (BRCA1-associated protein 2) ist essentiell für die embryonale Herzentwicklung und für den Ablauf des Zellzyklus in neonatalen Kardiomyozyten |
|
C. Grebe, P. Schott, B. Unsöld, J. Männer, M. Didié, K. Kurz, R. Knöll, K. Guan, G. Hasenfuß, T. Seidler (Göttingen, Eschwege; London, UK) |
| (V1567) |
Investigating coronary artery disease risk genes in murine knockout models: The Cardiovascular Gene Knockout Project (CardioGen KO-Project) |
|
Z. Aherrahrou, T. Keßler, J. Freyer, P. M. Rumpf, R. Aherrahrou, J. Al-Hasani, K. Schmidt, N. Alenina, M. Bader, C. de Wit, H. Schunkert, J. Erdmann (Lübeck, Berlin) |